Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Boston Scientific
(NY:
BSX
)
88.07
-1.96 (-2.18%)
Official Closing Price
Updated: 7:00 PM EST, Jan 16, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Boston Scientific
< Previous
1
2
...
16
17
18
19
20
21
22
23
Next >
Boston Scientific's Exalt Model B Single-Use Bronchoscope Wins FDA Approval
↗
August 11, 2021
The FDA has given 510(k) clearance for Boston Scientific Corp's (NYSE: BSX) Exalt Model B single-use bronchoscope for use in bedside procedures within the intensive...
Via
Benzinga
Unusual Options Activity Insight: Boston Scientific
↗
August 10, 2021
On Tuesday, shares of Boston Scientific (NYSE:BSX) saw unusu...
Via
Benzinga
Boston Scientific Recalls Faulty Pacemakers Due To Risk of Incorrect Transition To Safety Mode
↗
August 06, 2021
Boston Scientific Corporation (NYSE: BSX) is recalling Ingenio family pacemakers or cardiac resynchronization therapy pacemakers (CRT-Ps) devices due to the risk of...
Via
Benzinga
Topics
Product Recall
Boston Scientific Starts Trial For EkoSonic Endovascular System In Patients With Pulmonary Embolism
↗
August 04, 2021
Boston Scientific Corporation (NYSE: BSX) began enrollment for a clinical trial of its EkoSonic endovascular system (EKOS). Boston Scientific’s HI-PEITHO...
Via
Benzinga
'Fast Money Halftime Report' Picks For July 30
↗
July 30, 2021
On CNBC's "Fast Money Halftime Report," Shannon Saccocia picked salesforce.com, inc. (NYSE: CRM) as her final trade. The company is going to report earnings in few...
Via
Benzinga
Boston Scientific Corp (BSX) Q2 2021 Earnings Call Transcript
↗
July 27, 2021
BSX earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Why Boston Scientific Shares Are Trading Higher Today
↗
July 27, 2021
Boston Scientific (NYSE:BSX) shares are trading higher after ...
Via
Benzinga
Earnings Scheduled For July 27, 2021
↗
July 27, 2021
Companies Reporting Before The Bell • Navios Maritime Partners (NYSE:NMM) is projected to report quarterly earnings at $2.93 per share on revenue of $146.03 million....
Via
Benzinga
Why Boston Scientific's Stock Is Trading Lower Today
↗
May 26, 2021
Boston Scientific (NYSE:BSX) shares are trading lower af...
Via
Benzinga
The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business
↗
August 03, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 2) Absci, CORP (NASDAQ: ABSI) (...
Via
Benzinga
The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
↗
July 28, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc...
Via
Benzinga
Stock Market Rally Pauses Near Highs Amid Earnings From Apple, Microsoft, Tesla, Amazon, Google, Facebook
↗
July 30, 2021
The market rally paused on the key indexes amid earnings from Apple, Tesla and Amazon. But several stocks flashed buy signals.
Via
Investor's Business Daily
Topics
Economy
Stocks
Boston Scientific Earnings Top; BSX Stock Just Below Buy Point
↗
July 27, 2021
Boston Scientific earnings and revenue beat Q2 views for the medtech giant. BSX stock rose to just below a buy point.
Via
Investor's Business Daily
Stocks That Hit 52-Week Highs On Tuesday
↗
July 27, 2021
This morning 85 companies set new 52-week highs. Noteworthy Mentions: The largest company by market cap to set a new 52-week high was Alphabet (NASDAQ:GOOG). Intec...
Via
Benzinga
The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts
↗
July 27, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 26) Absci, CORP (NASDAQ: ABSI...
Via
Benzinga
Boston Scientific Earnings Exceed Expectations As Demand Picks Up, Raises FY21 Guidance
↗
July 27, 2021
Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.1 billion in Q2 of 2021, beating the estimate of $2.9 billion. Sales increased 53.6% Y/Y on a...
Via
Benzinga
Recap: Boston Scientific Q2 Earnings
↗
July 27, 2021
Shares of Boston Scientific (NYSE:BSX) fell 1.0% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share increased 400.00% year...
Via
Benzinga
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
↗
July 25, 2021
Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start...
Via
Benzinga
Unusual Options Activity Insight: Boston Scientific
↗
July 01, 2021
Boston Scientific (NYSE:BSX) shares experienced unusual options activity on Thursday. The stock price moved up to $43.24 following the option alert. Sentiment: BULLISH Option...
Via
Benzinga
Understanding Boston Scientific's Unusual Options Activity
↗
June 30, 2021
Shares of Boston Scientific (NYSE:BSX) saw some unusual options activity on Wednesday. Following the unusual option alert, the stock price moved down to $42.7. Sentiment:...
Via
Benzinga
Boston Scientific's Debt Overview
↗
June 24, 2021
Over the past three months, shares of Boston Scientific (NYSE:BSX) rose by 12.01%. Before we understand the importance of debt, let us look at how much debt Boston...
Via
Benzinga
Better Buy: Medtronic or Boston Scientific?
↗
June 03, 2021
Which one of these medical device makers is better poised for a breakout year?
Via
The Motley Fool
Pete Najarian Sees Unusual Options Activity In Boston Scientific And Deutsche Bank
↗
May 24, 2021
On CNBC's "Fast Money Halftime Report," Pete Najarian spoke about unusually high options activity in Boston Scientific Corporation (NYSE: BSX) and Deutsche Bank AG (...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 26, 2021
↗
May 26, 2021
Upgrades Bernstein upgraded the previous rating for Wipro Ltd (NYSE:WIT) from Underperform to Market Perform. Wipro earned $0.07 in the fourth quarter, compared to $0.05...
Via
Benzinga
BOSTON SCIENTIFIC INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Boston Scientific Corporation - BSX
May 14, 2021
From
Kahn Swick & Foti, LLC
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2021
↗
May 25, 2021
Upgrades For Appian Corp (NASDAQ:APPN), Macquarie upgraded the previous rating of Underperform to Neutral. For the first quarter, Appian had an EPS of $0.06, compared to...
Via
Benzinga
Pipelines Are ESG
↗
May 02, 2021
ESG is in the eye of the beholder. My favorite is Lockheed Martin, a perennial member of the Dow Jones Sustainability Index. If building weapons to blow up people and property can be done in a...
Via
Talk Markets
Topics
Stocks
Pete Najarian Sees Unusual Option Activity In Boston Scientific And Las Vegas Sands
↗
April 30, 2021
On CNBC's "Fast Money Halftime Report," Pete Najarian gave some unusual option activity plays. Najarian sees unusual activity in: Boston Scientific (NYSE: BSX) May $...
Via
Benzinga
Stock Market Rally Navigates Earnings From Apple, Tesla, Google, Facebook, Microsoft, Amazon
↗
April 30, 2021
The stock market rally navigated earnings from Apple, Tesla and the other "big six" market cap companies. Many breakouts, but not all succeeded.
Via
Investor's Business Daily
The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx
↗
April 29, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ:...
Via
Benzinga
< Previous
1
2
...
16
17
18
19
20
21
22
23
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today